Eva Soler-Espejo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Eva Soler-Espejo

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Clinical Cardiology|February 22, 2025

The Neutrophil-to-Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP-II) Cohort StudyEva Soler-Espejo, Francisco Marín, Raquel López-Gálvez, et al.

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 7, 2026

Early recurrence of atrial tachyarrhythmia after catheter ablation and its associations with clinical outcomes, atrial fibrillation burden, and blanking period duration: A post hoc analysis of the CABANA trialHongyu Liu, Runhui Hu, Wenhui Li, et al.

Clinical Cardiology|July 31, 2025

Evaluation of the Presence of Native Valvular Disease in Patients With Atrial Fibrillation Using the EHRA (Evaluated Heartvalves, Rheumatic, or Artificial) ClassificationAntonio Escolar Conesa, María Asunción Esteve-Pastor, Vanessa Roldán, et al.

Viruses|October 28, 2023

Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy RecipientsJosé Luis Piñana, Inmaculada Heras, Tommaso Francesco Aiello, et al.

Cell Reports. Medicine|December 20, 2023

NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapyLaura Hurtado-Navarro, Ernesto José Cuenca-Zamora, Lurdes Zamora, et al.

Frontiers in Oncology|July 17, 2024

Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapyJosé Luis Piñana, Lourdes Vazquez, Inmaculada Heras, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Clinical Cardiology|February 22, 2025

Clinical Cardiology|July 31, 2025

Viruses|October 28, 2023

Cell Reports. Medicine|December 20, 2023

NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapyLaura Hurtado-Navarro, Ernesto José Cuenca-Zamora, Lurdes Zamora, et al.

Frontiers in Oncology|July 17, 2024

Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapyJosé Luis Piñana, Lourdes Vazquez, Inmaculada Heras, et al.

Pageof 3